Evidence map›Paper›PMID 33986544›Full record

ArticleNature methods2021

Challenges in benchmarking metagenomic profilers.

Zheng Sun, Shi Huang, Meng Zhang, Qiyun Zhu, Niina Haiminen, Anna Paola Carrieri, Yoshiki Vázquez-Baeza, Laxmi Parida, Ho-Cheol Kim, Rob Knight and 1 more

Abstract read
In one paragraph

Article in Nature methods, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 79 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
79citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

79 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. ganon2: up-to-date and scalable metagenomics analysis.NAR genomics and bioinformatics · 2025
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. CoverM: read alignment statistics for metagenomics.Bioinformatics (Oxford, England) · 2025
    Article

19 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Zheng Sun *Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
Shi Huang *Department of Pediatrics, University of California, San Diego, La Jolla, CA, USA.
Meng ZhangKey Laboratory of Dairy Biotechnology and Engineering, Ministry of Education, Inner Mongolia Agricultural University, Hohhot, China.ORCID http://orcid.org/0000-0001-5841-4079
Qiyun ZhuDepartment of Pediatrics, University of California, San Diego, La Jolla, CA, USA.
Niina HaiminenIBM T. J. Watson Research Center, Yorktown Heights, NY, USA.ORCID http://orcid.org/0000-0002-8663-1019
Anna Paola CarrieriIBM Research Europe, The Hartree Centre, Warrington, UK.
Yoshiki Vázquez-BaezaDepartment of Pediatrics, University of California, San Diego, La Jolla, CA, USA.
Laxmi ParidaIBM T. J. Watson Research Center, Yorktown Heights, NY, USA.ORCID http://orcid.org/0000-0002-7872-5074
Ho-Cheol KimAI and Cognitive Software, IBM Research-Almaden, San Jose, CA, USA.
Rob KnightDepartment of Pediatrics, University of California, San Diego, La Jolla, CA, USA. robknight@eng.ucsd.edu.ORCID http://orcid.org/0000-0002-0975-9019
Yang-Yu LiuChanning Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA. yyl@channing.harvard.edu.ORCID http://orcid.org/0000-0003-2728-4907

Funding

Therapeutic Control of Aspirin-Exacerbated Respiratory DiseaseU19AI095219 · NIAID · BRIGHAM AND WOMEN'S HOSPITAL · PI Nora Amanda Barrett · 2011 to 2026
$29.1M
Genetic Epidemiology of COPDU01HL089856 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI SILVERMAN, EDWIN K · 2007 to 2021
$20.7M
Multi-omic approaches to mechanisms of vitamin D, environmental influences, and the microbiome on asthmaUH3OD023268 · OD · BRIGHAM AND WOMEN'S HOSPITAL · PI LITONJUA, AUGUSTO A, WEISS, SCOTT T · 2018 to 2022
$13.5M
IMMUNOLOGIC BASIS OF RESISTANCE AND HYPERSENSITIVITYT32AI007306 · NIAID · BRIGHAM AND WOMEN'S HOSPITAL · PI Nora Amanda Barrett, Joshua A Boyce · 1985 to 2026
$12.2M
Prospective Study of the Gut Microbiome in AgingRF1AG067744 · NIA · MASSACHUSETTS GENERAL HOSPITAL · PI CHAN, ANDREW T · 2020 to 2020
$11.7M
Functional Redundancy of Human Microbiome and its Implication in Fecal Microbiota TransplantationR01AI141529 · NIAID · BRIGHAM AND WOMEN'S HOSPITAL · PI LIU, YANG-YU · 2019 to 2023
$4.5M
Long-term health consequences of birth by cesarean sectionR01HD093761 · NICHD · HARVARD SCHOOL OF PUBLIC HEALTH · PI CHAVARRO, JORGE EDUARDO · 2018 to 2022
$3.3M
Prospective Study of the Gut Microbiome in AgingR01AG067744 · NIA · MASSACHUSETTS GENERAL HOSPITAL · PI CHAN, ANDREW T · 2025 to 2025
$944k
NHLBI NIH HHS U01 HL089856NIAID NIH HHS R01 AI141529NIAID NIH HHS T32 AI007306NIAID NIH HHS U19 AI095219NIA NIH HHS R01 AG067744NIA NIH HHS RF1 AG067744NICHD NIH HHS R01 HD093761NIH HHS UH3 OD023268
6 · The paper itself

Abstract

Accurate microbial identification and abundance estimation are crucial for metagenomics analysis. Various methods for classification of metagenomic data and estimation of taxonomic profiles, broadly referred to as metagenomic profilers, have been developed. Nevertheless, benchmarking of metagenomic profilers remains challenging because some tools are designed to report relative sequence abundance while others report relative taxonomic abundance. Here we show how misleading conclusions can be drawn by neglecting this distinction between relative abundance types when benchmarking metagenomic profilers. Moreover, we show compelling evidence that interchanging sequence abundance and taxonomic abundance will influence both per-sample summary statistics and cross-sample comparisons. We suggest that the microbiome research community pay attention to potentially misleading biological conclusions arising from this issue when benchmarking metagenomic profilers, by carefully considering the type of abundance data that were analyzed and interpreted and clearly stating the strategy used for metagenomic profiling.

Indexed as

MetagenomicsComputational BiologyGene Expression ProfilingMicrobiotaSequence Analysis, DNA

Identifiers

PMID33986544
PMCPMC8184642

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.